Amgen logo

Amgen Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Amgen holds $92.5B in total assets. Shareholders' equity is $9.2B against $57.3B in total debt. Cash and equivalents total $559.0M. The current ratio is 1.26 and debt-to-equity is 6.24. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$183.12B
P/E Ratio23.48
ROE101.32%

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Cumulative Cost Basis$11.5B$8.3B$7.5B$8.7B$8.5B$11.5B
Fair Value Measurement Disclosure$1.0B$880.0M$1.0B$904.0M$827.0M$792.0M
Gross Assets/Liabilities$1.0B$880.0M$1.0B$904.0M$827.0M$792.0M
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax$0.0$0.0$0.0$0.0$0.0$0.0
Gross Unrealized Gains$0.0$0.0$0.0$0.0$0.0$0.0
Total$11.5B$8.3B$7.5B$8.7B$8.5B$11.5B
Available for sale investments$11.5B$8.3B$7.5B$8.7B$8.5B$11.5B
Business Combination, Contingent Consideration, Liability$106.0M$104.0M$90.0M$95.0M$161.0M$173.0M
Common stock, par value (in dollars per share)$0.0$0.0$0.0$0.0$0.0$0.0
Common stock, shares authorized (in shares)$2.8B$2.8B$2.8B$2.8B$2.8B$2.8B
Common Stock, Shares, Outstanding$536.9M$537.7M$538.3M$538.5M$538.8M$539.7M
Debt issuances$4.0B
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net$1.4B$1.3B$1.3B$1.3B$1.3B$1.3B
Deferred income taxes$1.6B$1.5B$1.4B$1.5B$1.4B$1.3B
Derivative, gross, assets$420.0M$195.0M$109.0M$142.0M$244.0M$249.0M
Derivatives, gross, liabilities$1.0B$880.0M$1.0B$904.0M$827.0M$792.0M
Finite-Lived Intangible Assets, Accumulated Amortization$28.4B$29.6B$30.8B$31.9B$32.8B$33.7B
2028$3.7B$3.7B$3.5B$2.8B
2030$2.2B$2.3B$2.3B$2.2B
2031$2.1B$2.2B$2.2B$2.1B
Remainder of 2026$3.1B$2.0B$900.0M$2.7B
2027$3.7B$3.7B$3.6B$3.6B
2029$2.8B$2.9B$2.8B$2.3B
Gross Carrying Amount$55.1B$54.3B$54.7B$54.3B$54.4B$54.3B
Identifiable Intangible Assets Accumulated Amortization$28.4B$29.6B$30.8B$31.9B$32.8B$33.7B
Identifiable Intangible Assets Gross$56.1B$55.3B$55.4B$55.0B$55.1B$55.0B
Amount outstanding under the credit facility$0.0$0.0
Syndicated, unsecured revolving credit facility capacity$4.0B
Other (including finance leases)$24.0M$28.0M$26.0M$24.0M$27.0M$25.0M
Share Repurchase Program, Remaining Authorized, Amount$6.8B$6.8B$6.8B$6.8B
Remainder of Fiscal Year 2024$3.1B$2.0B$900.0M$2.7B
Remainder of Fiscal Year 2025$3.1B$2.0B$900.0M$2.7B